Comparison of efficacy outcomes for Carfilzomib plus Dexamethasone and Daratumumab (KdD) versus Pomalidomide plus Bortezomib and Dexamethasone (PVd) and D-Pd in relapsed or refractory Multiple Myeloma

被引：0

作者：

Chari, Ajai ^{[1
]}

Dimopoulos, Meletios-Athanasios ^{[2
]}

Beksac, Meral ^{[3
]}

Leleu, Xavier ^{[4
,5
]}

Weisel, Katja ^{[6
]}

Richter, Joshua ^{[7
]}

Dirnberger, Franziska ^{[8
]}

Iskander, Karim ^{[8
]}

Yusuf, Akeem ^{[8
]}

Mikhael, Joseph ^{[9
]}

机构：

[1] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA

[2] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Sch Med, Alexandra Gen Hosp, Athens, Greece

[3] Ankara Univ, Ankara, Turkey

[4] CHU, Serv Hematol & Therapie Cellulaire, Poitiers, France

[5] CIC Inserm 1402, Poitiers, France

[6] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Hamburg, Germany

[7] Mt Sinai Hosp, Icahn Sch Med, New York, NY 10029 USA

[8] Amgen Inc, Thousand Oaks, CA 91320 USA

[9] City Hope Canc Ctr, Translat Genom Res Inst TGen, Duarte, CA USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-191

引用

页码：S142 / S142

页数：1

共 50 条

[41] Results From the Randomized Phase 3 DREAMM-8 Study of Belantamab Mafodotin, Pomalidomide, Dexamethasone vs Pomalidomide Plus Bortezomib, Dexamethasone (PVd) in Relapsed/Refractory Multiple Myeloma [J].

Trudel, Suzanne ;

Beksac, Meral ;

Pour, Ludek ;

Delimpasi, Sosana ;

Vorobyev, Vladimir ;

Hang Quach ;

Spicka, Ivan ;

Radocha, Jakub ;

Robak, Pawel ;

Kim, Kihyun ;

Cavo, Michele ;

Suzuki, Kazuhito ;

Morris, Kristin ;

Pompilus, Farrah ;

Wilkes, Jodie ;

Philips-Jones, Amy ;

Zhou, Xiaoou ;

Fulci, Giulia ;

Sule, Neal ;

Kremer, Brandon ;

Opalinska, Joanna ;

Mateos Manteca, Maria-Victoria ;

Dimopoulos, Meletios .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S39-S40

[42] Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design [J].

Moreau, Philippe ;

Dimopoulos, Meletios A. ;

Yong, Kwee ;

Mikhael, Joseph ;

Risse, Marie-Laure ;

Asset, Gaelle ;

Martin, Thomas .

FUTURE ONCOLOGY, 2020, 16 (02) :4347-4358

[43] A SINGLE CENTER EXPERIENCE OF POMALIDOMIDE PLUS DEXAMETHASONE (PD) IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) [J].

Duran, M. ;

Tombuloglu, M. ;

Tobu, M. ;

Vural, F. ;

Sahin, F. ;

Patir, P. ;

Uysal, A. ;

Saydam, G. .

LEUKEMIA RESEARCH, 2016, 49 :S18-S19

[44] Comparative Efficacy of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Aged 70 and Above: A Multicenter Study [J].

Mansour, Razan ;

Green, Kimberly M. ;

Chang, Mark ;

Magee, Gray ;

Davis, James A. ;

Atrash, Shebli ;

Ahmed, Nausheen ;

Mushtaq, Muhammad Umair ;

Ouchveridze, Evguenia ;

Mahmoudjafari, Zahra ;

Abdallah, Al-Ola ;

Paul, Barry ;

Twardowski, Nicole ;

Hashmi, Hamza .

BLOOD, 2024, 144 :1965-1966

[45] Indirect Comparisons to Assess the Relative Efficacy of Carfilzomib plus Lenalidomide plus Dexamethasone Versus Panobinostat plus Bortezomib plus Dexamethasone and Bortezomib plus Dexamethasone: A Matching Adjusted Indirect Comparison [J].

Rael, Michael ;

Benedict, Agnes ;

Ishak, Jack ;

Cadarette, Sarah ;

Campioni, Marco ;

Panjabi, Sumeet .

BLOOD, 2015, 126 (23)

[46] Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma [J].

Yee, Andrew J. ;

Laubach, Jacob P. ;

Campagnaro, Erica L. ;

Lipe, Brea C. ;

Nadeem, Omar ;

Friedman, Robb S. ;

Cole, Craig E. ;

O'Donnell, Elizabeth K. ;

Bianchi, Giada ;

Branagan, Andrew R. ;

Schlossman, Robert L. ;

Shapiro, Samantha J. ;

Harrington, Cynthia C. ;

Burke, Jill N. ;

Gammon, Marilyn T. ;

Lively, Kathleen J. ;

Reimonn, Cassandra A. ;

Andrade, Danielle X. ;

Redd, Robert ;

Lohr, Jens G. ;

Anderson, Kenneth C. ;

Richardson, Paul G. ;

Raje, Noopur S. .

BLOOD ADVANCES, 2025, 9 (05) :1163-1170

[47] Health-Related Quality of Life With Pomalidomide plus Dexamethasone plus Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients [J].

Reece, Donna ;

Bahlis, Nizar J. ;

Samaras, Christy Joy ;

Sebag, Michael ;

Berdeja, Jesus ;

Ganguly, Siddhartha ;

Matous, Jeffrey ;

Song, Kevin ;

Seet, Christopher S. ;

Talamo, Giampaolo ;

Acosta-Rivera, Mirelis ;

Bar, Michael ;

Quick, Donald ;

Anz, Bertrand ;

Fonseca, Gustavo ;

Agarwal, Amit ;

Chung, Weiyuan ;

Zafar, Faiza ;

Siegel, David S. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) :E277-E278

[48] Efficacy of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in High Risk Relapsed Multiple Myeloma: Multicenter Real-World Experience [J].

Magee, Gray ;

Mansour, Razan ;

Chang, Mark ;

Atrash, Shebli ;

Ahmed, Nausheen ;

Mushtaq, Muhammad Umair ;

Ouchveridze, Evguenia ;

Abdallah, Al-Ola ;

Paul, Barry ;

Green, Kimberly M. ;

Davis, James A. ;

Hashmi, Hamza .

BLOOD, 2024, 144 :7034-7035

[49] DREAMM-8: A phase III study of the efficacy and safety of belantamab mafodotin with pomalidomide and dexamethasone vs pomalidomide plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma [J].

Trudel, Suzanne ;

Davis, Randy ;

Lewis, Nicole M. ;

Bakshi, Kalpana K. ;

Chopra, Bikramjit ;

de Oca, Rocio Montes ;

Ferron-Brady, Geraldine ;

Eliason, Laurie ;

Kremer, Brandon E. ;

Stowell, Delia ;

Gupta, Ira ;

Wu, Frank S. .

BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 :177-177

[50] UPDATED EFFICACY AND SAFETY ANALYSIS OF DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (DVD) VERSUS BORTEZOMIB AND DEXAMETHASONE (VD) FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM; CASTOR) [J].

Mateos, M. M. ;

Spencer, A. ;

Hungria, V ;

Nooka, A. K. ;

Estell, J. ;

Barreto, W. ;

Corradini, P. ;

Min, C. K. ;

Medvedova, E. ;

Thiyagarajah, P. ;

Deraedt, W. ;

Chiu, C. ;

Schecter, J. M. ;

Weisel, K. .

HAEMATOLOGICA, 2018, 103 :30-30

← 1 2 3 4 5 →